A role for proteoglycans in vascular disease.

Area of Science:

• Vascular Biology
• Extracellular Matrix Biology
• Proteoglycan Research

Background:

• Proteoglycans (PGs) are typically low in vascular extracellular matrix (ECM) but increase significantly during vascular disease.
• Glycosaminoglycans (GAGs) like chondroitin sulfate (CS), dermatan sulfate (DS), keratan sulfate (KS), and heparan sulfate (HS) accumulate in vascular lesions, often near lipid deposits.

Purpose of the Study:

• To provide a historical perspective on proteoglycan research in vascular disease.
• To highlight the involvement and roles of PGs in the pathogenesis of vascular disease.

Main Methods:

• Review of early and later studies on GAG and PG accumulation in vascular lesions.
• Analysis of the structural diversity and functional roles of different PG families.
• Examination of PG interactions with various molecules and cells in vascular disease.

Main Results:

• GAGs covalently attach to core proteins (e.g., versican, biglycan, decorin, lumican, fibromodulin, perlecan) that accumulate in lesions.
• PGs exhibit structural diversity, playing selective roles in vascular disease pathogenesis.
• PGs bind lipoproteins, amyloid, calcium, and clotting factors; regulate ECM; and alter cell phenotypes.

Conclusions:

• Proteoglycans play critical roles in vascular disease pathogenesis through diverse interactions.
• Understanding PG involvement provides a basis for developing targeted therapeutic strategies for vascular conditions.